Autoimmune disorders in patients with idiopathic thrombotic thrombocytopenic purpura^[*]

Summary

76 German patients suffering from thrombotic thrombocytopenic purpura (TTP) were interrogated about the prevalence of cooccurring autoimmune disorders. In order to analyze a possible association of TTP with the questioned diseases, a comparison of prevalence rates between the patient group and the general population has been made for each disease. Results: Compared to the estimated prevalence rates, the statistical analysis revealed an unexpected high occurrence of the following disorders within the patient group: Hashimoto’s thyroiditis (23.5% within the patients compared to 0.7% within the general population, p<0.001), systemic lupus erythematosus (SLE) (6.5% in patients to 0.025% in the general population, p<0.001), immune thrombocytopenic purpura (ITP) (6.3% in patients to 0.02% in the general population, p < 0.001), psoriasis (9.4% in patients to 2.5% in the general population, p = 0.005) and celiac disease (3.1% in patients to 0.2% in the general population, p = 0.007). Conclusion: These findings confirm the mentioned tendency of autoimmune diseases to co-occur in one individual and argue once more for a genetic susceptibility in idiopathic TTP as well as in autoimmune disorders.

Zusammenfassung

Bei 76 deutschen Patienten mit thrombotisch untersucht. Als Vergleichswerte dienten die zugehörigen Prävalenzen für die jeweilige Erkrankung in der Allgemeinbevölkerung. Die statistische Auswertung erfolgte mit dem zweiseitigen Binomialtest.Ergebnisse: Im Vergleich mit den Prävalenzen in der Allgemeinbevölkerung, zeigte sich für fünf Erkrankungen ein gehäuftes Auftreten im Patientenkollektiv: Hashimoto-Thyreoiditis (23,5% in der Patientengruppe zu 0,7% in der Allgemeinbevölkerung; p < 0,001), systemischer Lupus erythematodes (SLE) (6,5% der Patienten im Gegensatz zu 0,025% in der Allgemeinbevölkerung, p < 0,001), Immunthrombozytopenie (ITP) (6,3% der Patienten zu 0,02% in der Allgemeinbevölkerung; p < 0,001), Psoriasis (9,4% der Patienten zu 2,5% in der Allgemeinbevölkerung; p = 0,005) und Zöliakie (3,1% der Patienten zu 0,2% in der Allgemeinbevölkerung; p = 0,007). Schlussfolgerung: Diese Ergebnisse sprechen für eine Assoziation verschiedener Autoimmunkrankheiten untereinander und unterstützen die Annahme einer möglichen genetischen Prädisposition zur Ausbildung mehrerer autoimmuner Störungen innerhalb eines Individuums.

Keywords

TTP - autoimmunity - genetic susceptibility - HLA

Schlüsselwörter

TTP - Autoimmunität - genetische Prädisposition - HLA

• References

• 1 Altintas A, Pasa S, Cil T. et al. Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura. Platelets 2008; 19: 252-257.
• 2 Badenhoop K, Dieterich W, Segni M. et al. HLA DQ2 and/or DQ8 is associated with celiac disease-specific autoantibodies to tissue transglutaminase in families with thyroid autoimmunity. Am J Gastroenterol 2001; 96: 1648-1649.
• 3 Baron BW, Martin MS, Sucharetza BS. et al. Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: The concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange. J Clin Apheresis 2001; 16: 179-185.
• 4 Braun J, Bollow M, Remlinger G. et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67.
• 5 Epidemiologie der Immunthrombozytopenie (ITP. [cited 2012 Feb 22]. www.onkodin.de/ e8/e63554/e63558/e63579/.
• 6 Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009; 11: 229.
• 7 Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology 2006; 45 (Suppl. 03) aiii3-iii4.
• 8 Graham RR, Ortmann W, Rodine P. et al. Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE. Eur J Hum Genet 2007; 15: 823-830.
• 9 Hein T, Hopfenmüller W. Projection of the number of multiple sclerosis patients in Germany. Nervenarzt 2000; 71: 288-294.
• 10 Hermann-Kunz E. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz. 2000; 43: 400-406.
• 11 Heward J, Gough SC. Genetic susceptibility to the development of autoimmune disease. Clin Sci 1997; 93: 479-491.
• 12 Jenisch S, Henseler T, Nair RP. et al. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 1998; 63: 191-199.
• 13 John M-L, Hitzler W, Scharrer I. The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura. Ann Hematol 2012; 91: 507-510.
• 14 Kleinert S, Feuchtenberger M, Tony H-P. Systemischer Lupus erythematodes. Internist 2010; 51: 1013-1028.
• 15 Letchumanan P, Ng H-J, Lee L-H, Thumboo J. A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus. Rheumatology (Oxford) 2009; 48: 399-403.
• 16 McLoughlin R, Sebastian SS. et al. Coeliac disease in Europe. Aliment Pharmacol Ther 2003; 18 (Suppl. 03) 45-48.
• 17 Farid NR, Sampson L, Moens H, Barnard JM. The association of goitrous autoimmune thyroiditis with HLA-DR5*. Tissue Antigens 2008; 17: 265-268.
• 18 Molodecky NA, Soon IS, Rabi DM. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
• 19 Neame PB. Immunologic and other factors in thrombotic thrombocytopenic purpura (TTP). Semin Thromb Hemost 1980; 06: 416-429.
• 20 Schäfer T. Epidemiology of Psoriasis. Dermatology 2006; 212: 327-337.
• 21 Schumm-Dräger PM, Feldkamp J. Schilddrüsen-krankheiten in Deutschland. Prävention und Gesundheitsförderung 2007; 02: 153-158.
• 22 Worm M, Forschner K, Lee H-H. et al. Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol 2006; 86: 119-122.